Novartis Prevails In Patent Suit Vs. Dr. Reddy's Over Lamisil
Swiss drug giant Novartis has fended off a patent challenge from Indian generic maker Dr. Reddy's against its widely prescribed oral antifungant Lamisil....To view the full article, register now.
Already a subscriber? Click here to view full article